15(S)-15-Methyl prostaglandin F2alpha elicits marked peripheral airway constriction in the intact dog.
D000019:Abortifacient Agents / Q000494:pharmacology*; D000020:Abortifacient Agents, Nonsteroidal / Q000494:pharmacology*; D000403:Airway Resistance / Q000187:drug effects*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004347:Drug Interactions; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008168:Lung / Q000098:blood supply; D011460:Prostaglandins F / Q000494:pharmacology; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; D001285:Atropine